{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:39:23Z","timestamp":1787755163986,"version":"build-2784847793"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T00:00:00Z","timestamp":1489104000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBJS OA"],"published-print":{"date-parts":[[2017,3,30]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Postoperative hyperglycemia related to stress has been shown to be an independent risk factor for periprosthetic joint infection. In a non-intensive care, general-surgery setting, a standardized postoperative insulin protocol has been shown to decrease the rate of wound infections. We hypothesized that the use of a similar protocol is both safe and effective for controlling hyperglycemia in patients who have undergone total joint replacement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study of 489 consecutive patients who underwent primary or revision total hip or knee arthroplasty between January 2008 and April 2013. All patients were tested with point-of-care (finger-stick) glucose determinations postoperatively and were started on a subcutaneous insulin protocol if they had postoperative stress hyperglycemia of &gt;140 mg\/dL when fasting or &gt;180 mg\/dL after meals. Insulin was discontinued when blood glucose decreased to &lt;100 mg\/dL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of the 489 patients, 301 (62%) qualified for the insulin protocol. Thirty-seven (17%) of the 220 patients for whom the hemoglobin A1c level was available were diabetic, and 21 (11%) of the 187 patients for whom body mass index data were available were morbidly obese (body mass index, \u226540 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ). Diabetes (p &lt; 0.001), revision surgery (p &lt; 0.001), male sex (p = 0.0110), and obesity (including morbid obesity) (p = 0.0051) were independent factors resulting in significant glycemic elevation. A trend toward hyperglycemia occurred in younger patients but did not reach significance (p = 0.063). The glucose levels of patients in all of these groups responded well to insulin. None of the patients who were managed with the insulin experienced a periprosthetic joint infection. There were no injuries related to hypoglycemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The findings of the present study suggest that hyperglycemia is a common link between seemingly disparate factors related to the increased prevalence of periprosthetic joint infection. The standardized subcutaneous insulin protocol was both safe and effective for the treatment of hyperglycemia for nondiabetic as well as diabetic patients. Patients who have undergone total joint replacement, especially those with revision procedures, male sex, morbid obesity, and diabetes, should be evaluated for hyperglycemia starting in the post-anesthesia care unit and should be managed with the insulin protocol when that risk is identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level IV<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.oa.16.00008","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T07:24:37Z","timestamp":1489130677000},"page":"e0008","source":"Crossref","is-referenced-by-count":22,"title":["Postoperative Hyperglycemia Can Be Safely and Effectively Controlled in Both Diabetic and Nondiabetic Patients with Use of a Subcutaneous Insulin Protocol"],"prefix":"10.2106","volume":"2","author":[{"given":"John M.","family":"Gallagher","sequence":"first","affiliation":[{"name":"Mercy West Hospital, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Erich","sequence":"additional","affiliation":[{"name":"University of Dayton, Dayton, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Gattermeyer","sequence":"additional","affiliation":[{"name":"Mercy West Hospital, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn K.","family":"Beam","sequence":"additional","affiliation":[{"name":"Mercy West Hospital, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"issue":"1","key":"R1-20230811","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/diab.23.1.9","article-title":"Impaired leukocyte function in patients with poorly controlled diabetes","volume":"23","author":"Bagdade","year":"1974","journal-title":"Diabetes"},{"issue":"2","key":"R2-20230811","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/diacare.15.2.256","article-title":"Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes","volume":"15","author":"Marhoffer","year":"1992","journal-title":"Diabetes Care"},{"issue":"2","key":"R3-20230811","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/193229681100500231","article-title":"Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty","volume":"5","author":"Mraovic","year":"2011","journal-title":"J Diabetes Sci Technol"},{"issue":"14","key":"R4-20230811","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.2106\/JBJS.J.01935","article-title":"Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis","volume":"94","author":"J\u00e4msen","year":"2012","journal-title":"J Bone Joint Surg Am."},{"issue":"9","key":"R5-20230811","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2106\/JBJS.L.00494","article-title":"Elevated postoperative blood glucose and preoperative hemoglobin A1C are associated with increased wound complications following total joint arthroplasty","volume":"95","author":"Stryker","year":"2013","journal-title":"J Bone Joint Surg Am."},{"issue":"5","key":"R6-20230811","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.arth.2011.09.013","article-title":"Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection","volume":"27","author":"Iorio","year":"2012","journal-title":"J Arthroplasty"},{"issue":"3","key":"R7-20230811","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.arth.2014.10.009","article-title":"Diabetes mellitus, hyperglycemia, hemoglobin A1C and the risk of prosthetic joint infections in total hip and knee arthroplasty","volume":"30","author":"Maradit Kremers","year":"2015","journal-title":"J Arthroplasty"},{"issue":"7","key":"R8-20230811","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.arth.2015.01.040","article-title":"Is hemoglobin A1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty?","volume":"30","author":"Chrastil","year":"2015","journal-title":"J Arthroplasty"},{"issue":"13","key":"R9-20230811","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2106\/JBJS.K.00193","article-title":"Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery","volume":"94","author":"Richards","year":"2012","journal-title":"J Bone Joint Surg Am."},{"issue":"7","key":"R10-20230811","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acr.21953","article-title":"Sex and surgical outcomes and mortality after primary total knee arthroplasty: a risk-adjusted analysis","volume":"65","author":"Singh","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"R11-20230811","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.arth.2013.04.015","article-title":"Risk factors for periprosthetic joint infection following primary total hip arthroplasty: a case control study","volume":"29","author":"Bozic","year":"2014","journal-title":"J Arthroplasty"},{"issue":"3","key":"R12-20230811","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.arth.2012.06.027","article-title":"In-hospital surgical site infections after primary hip and knee arthroplasty\u2014incidence and risk factors","volume":"28","author":"Poultsides","year":"2013","journal-title":"J Arthroplasty"},{"issue":"1","key":"R13-20230811","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11999-009-1013-5","article-title":"Prosthetic joint infection risk after TKA in the Medicare population","volume":"468","author":"Kurtz","year":"2010","journal-title":"Clin Orthop Relat Res."},{"issue":"7","key":"R14-20230811","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2106\/JBJS.M.00545","article-title":"Younger age is associated with a higher risk of early periprosthetic joint infection and aseptic mechanical failure after total knee arthroplasty","volume":"96","author":"Meehan","year":"2014","journal-title":"J Bone Joint Surg Am."},{"issue":"6","key":"R15-20230811","first-page":"24","article-title":"Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates","author":"Malinzak","year":"2009","journal-title":"J Arthroplasty"},{"issue":"7","key":"R16-20230811","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s11999-008-0209-4","article-title":"Periprosthetic joint infection: the incidence, timing, and predisposing factors","volume":"466","author":"Pulido","year":"2008","journal-title":"Clin Orthop Relat Res."},{"issue":"3","key":"R17-20230811","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2106\/JBJS.O.00430","article-title":"Effect of body mass index on complications and reoperations after total hip arthroplasty","volume":"98","author":"Wagner","year":"2016","journal-title":"J Bone Joint Surg Am."},{"issue":"3","key":"R18-20230811","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.arth.2015.09.033","article-title":"How much do adverse event rates differ between primary and revision total joint arthroplasty?","volume":"31","author":"Bohl","year":"2016","journal-title":"J Arthroplasty"},{"issue":"9","key":"R19-20230811","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archsurg.2010.179","article-title":"Postoperative hyperglycemia and surgical site infection in general surgery patients","volume":"145","author":"Ata","year":"2010","journal-title":"Arch Surg"},{"issue":"2","key":"R20-20230811","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0003-4975(99)00014-4","article-title":"Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures","volume":"67","author":"Furnary","year":"1999","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"R21-20230811","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0003-4975(96)01044-2","article-title":"Glucose control lowers the risk of wound infection in diabetics after open heart operations","volume":"63","author":"Zerr","year":"1997","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"R22-20230811","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jtcvs.2005.05.049","article-title":"Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery","volume":"130","author":"Doenst","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"R23-20230811","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"R24-20230811","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"R25-20230811","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Endocrine Society. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"R26-20230811","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1932296813520367","article-title":"Basal insulin use in the non-critical care setting: is fasting hypoglycemia inevitable or preventable?","volume":"8","author":"Flory","year":"2014","journal-title":"J Diabetes Sci Technol"}],"container-title":["JBJS Open Access"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01960901-201703000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:38:33Z","timestamp":1787751513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01960901-201703000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.oa.16.00008","relation":{},"ISSN":["2472-7245"],"issn-type":[{"value":"2472-7245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]}}}